123 related articles for article (PubMed ID: 14684419)
21. Ethnicity and body mass index are associated with hepatitis C presentation and progression.
Kallwitz ER; Layden-Almer J; Dhamija M; Berkes J; Guzman G; Lepe R; Cotler SJ; Layden TJ
Clin Gastroenterol Hepatol; 2010 Jan; 8(1):72-8. PubMed ID: 19686868
[TBL] [Abstract][Full Text] [Related]
22. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
23. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan.
Mizuochi T; Takano T; Yanagi T; Ushijima K; Suzuki M; Miyoshi Y; Ito Y; Inui A; Tajiri H
J Gastroenterol; 2018 Mar; 53(3):419-426. PubMed ID: 28567493
[TBL] [Abstract][Full Text] [Related]
24. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
Seeff LB; Hoofnagle JH
Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of hepatitis C in survivors of paediatric malignancy.
Carter TL; Cole CH; Mews CF; Price PJ; Baker DL
J Paediatr Child Health; 1997 Jun; 33(3):238-41. PubMed ID: 9259300
[TBL] [Abstract][Full Text] [Related]
26. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
[TBL] [Abstract][Full Text] [Related]
27. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
29. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage.
Serra MA; Rodríguez F; del Olmo JA; Escudero A; Rodrigo JM
J Viral Hepat; 2003 May; 10(3):183-8. PubMed ID: 12753336
[TBL] [Abstract][Full Text] [Related]
30. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.
Minola E; Prati D; Suter F; Maggiolo F; Caprioli F; Sonzogni A; Fraquelli M; Paggi S; Conte D
Blood; 2002 Jun; 99(12):4588-91. PubMed ID: 12036892
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of HCV infection: disease and renal transplantation.
Cisterne JM; Rostaing L; Izopet J; Chabannier MH; Baron E; Duffaut M; Durand D; Suc JM
Nephrol Dial Transplant; 1996; 11 Suppl 4():46-7. PubMed ID: 8918753
[TBL] [Abstract][Full Text] [Related]
32. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
Luban NL; Colvin CA; Mohan P; Alter HJ
Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
[TBL] [Abstract][Full Text] [Related]
34. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C.
Mailliard ME; Capadano ME; Hrnicek MJ; Gilroy RK; Gulizia JM
Hepatology; 2009 Aug; 50(2):361-8. PubMed ID: 19585621
[TBL] [Abstract][Full Text] [Related]
36. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study.
Wiese M; Grüngreiff K; Güthoff W; Lafrenz M; Oesen U; Porst H;
J Hepatol; 2005 Oct; 43(4):590-8. PubMed ID: 16237783
[TBL] [Abstract][Full Text] [Related]
37. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Jonas MM; Baron MJ; Bresee JS; Schneider LC
Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
[TBL] [Abstract][Full Text] [Related]
38. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
Hines MR; Mulrooney DA; Hudson MM; Ness KK; Green DM; Howard SC; Krasin M; Metzger ML
J Cancer Surviv; 2016 Feb; 10(1):113-21. PubMed ID: 26044903
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
